Health Condition 1: null- Cases are patients with superficial dermatophytosis and controls are healthy volunteers
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Study population 1.All patients above the age of 12 years diagnosed clinically to have recurrent dermatophytoses (excluding nail and scalp infections). Control Group: 1.First episode or Only single episode of tinea corporis/cruris/facei in last 12 months The inclusion criteria for centres: 1.There should be an NABL-accredited mycology laboratory equipped for standardized dermatophyte cuture available (the proof of such accreditation must be attached with the application). 2. The lab director or the mycologist in-charge must give signed consent in a pre-approved format: 1) agreeing to be a co-investigator for the project, and 2) agreeing to give unimpeded access to the lab for the said purpose (dermatophyte culture) during the full tenure of the project. 3. The Investigator must take full responsibility of and provide proof thereof facilities of transportation of biological samples from the site to PGIMER.
Exclusion criteria
Exclusion criteria: 1.Immunocompromised. 2.Pregnancy 3.Lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To estimate the prevalence and clinical patterns of recurrent dermatophytoses (excluding nail and scalp infections). Timepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the host and environmental risk factors associated with recurrent dermatophytoses. 2. To study the antifungal susceptibility patterns in these patients. 3. To study relationship between the potency and quantity of corticosteroid use with severity and chronicity of dermatophytosis Timepoint: 1 year | — |
Countries
India
Contacts
Post Graduate Institute of Medical Education and Research,Chandigarh